Inventor · disambiguated record
David G. Winkler
Also filed as: WINKLER DAVID · WINKLER DAVID G · WINKLER DAVID GUENTHER
35 granted patents·18 pending applications·1,431 citations·filing 1999–2024
98Inventor score
Files withNOVARTIS AG11UCB PHARMA SA10CELLTECH R & D INC6INFINITY PHARMACEUTICALS INC6DARWIN DISCOVERY LTD5
Top patents by PatentIndex Score
53 records- 0198US6803453B1Antibodies associated with alterations in bone densityDARWIN DISCOVERY LTD·Filed 2000·Granted Oct 12, 2004·267 cites·12 claims
- 0298US6489445B1Polypeptides associated with alterations in bone densityCELLTECH R & D INC·Filed 2000·Granted Dec 3, 2002·121 cites·10 claims
- 0398US6395511B1Nucleic acids encoding a novel family of TGF-β binding proteins from humansDARWIN DISCOVERY LTD·Filed 1999·Granted May 28, 2002·168 cites·16 claims
- 0497US7872106B2Sclerostin-binding antibodiesAMGEN INC·Filed 2008·Granted Jan 18, 2011·86 cites·25 claims
- 0597US7758858B2Antibodies associated with alterations in bone densityDARWIN DISCOVERY LTD·Filed 2004·Granted Jul 20, 2010·46 cites·21 claims
- 0697US7578999B2Antibodies specific for sclerostinCELLTECH R & D INC·Filed 2006·Granted Aug 25, 2009·66 cites·23 claims
- 0797US7572899B2Compositions and methods for increasing bone mineralizationUCB SA·Filed 2002·Granted Aug 11, 2009·55 cites·12 claims
- 0897US7381409B2Antibodies specific for sclerostin and methods of screening and use thereforCELLTECH R & D INC·Filed 2004·Granted Jun 3, 2008·68 cites·16 claims
- 0997US7192583B2Methods for modulating bone mineralizationDARWIN DISCOVERY LTD·Filed 2003·Granted Mar 20, 2007·78 cites·5 claims
- 1097US6495736B1Compositions and methods for increasing bone mineralizationDARWIN DISCOVERY LTD·Filed 2000·Granted Dec 17, 2002·115 cites·2 claims
- 1196US7868134B2Immunogenic peptides derived from sclerostinUCB MFG INC·Filed 2008·Granted Jan 11, 2011·49 cites·20 claims
- 1296US7592429B2Sclerostin-binding antibodyUCB SA·Filed 2006·Granted Sep 22, 2009·166 cites·5 claims
- 1394US9775844B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2015·Granted Oct 3, 2017·13 cites·48 claims
- 1494US9011856B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Apr 21, 2015·7 cites·30 claims
- 1594US8992911B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Mar 31, 2015·7 cites·17 claims
- 1692US10675286B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2017·Granted Jun 9, 2020·4 cites·19 claims
- 1791US11541059B2Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2020·Granted Jan 3, 2023·2 cites·11 claims
- 1890US11724992B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2021·Granted Aug 15, 2023·1 cites·20 claims
- 1990US9527847B2Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Dec 27, 2016·12 cites·35 claims
- 2089US8828998B2Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitorsINFINITY PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·11 cites·48 claims
- 2189US8563271B2Antibodies specific for sclerostin and methods for increasing bone mineralizationWINKLER DAVID G·Filed 2012·Granted Oct 22, 2013·7 cites·28 claims
- 2289US7226902B2Ligands for TGF-beta binding proteins and uses thereofCELLTECH R & D INC·Filed 2004·Granted Jun 5, 2007·53 cites·3 claims
- 2389US2024209075A1Antibodies Specific for Sclerostin and Methods for Increasing Bone MineralizationUCB PHARMA SA·Filed 2023·Application pending·0 cites
- 2488US8637643B2Sclerostin binding antibodyLATHAM JOHN·Filed 2013·Granted Jan 28, 2014·9 cites·5 claims
- 2587US8003108B2Sclerostin epitopesAMGEN INC·Filed 2006·Granted Aug 23, 2011·11 cites·15 claims
- 2684US12084424B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2023·Granted Sep 10, 2024·0 cites·3 claims
- 2784US11370763B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Jun 28, 2022·1 cites·13 claims
- 2884US10654816B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS INFLAMMASOME RES INC·Filed 2019·Granted May 19, 2020·3 cites·19 claims
- 2981US11203579B2Compounds and compositions for treating conditions associated with NLRP activityNOVARTIS AG·Filed 2018·Granted Dec 21, 2021·2 cites·19 claims
- 3081US9791462B2Compositions and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2015·Granted Oct 17, 2017·1 cites·2 claims
- 3179US7985834B2Compositions and methods for increasing bone mineralizationCELLTECH R & D INC·Filed 2009·Granted Jul 26, 2011·2 cites·5 claims
- 3278US11702468B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2019·Granted Jul 18, 2023·0 cites·2 claims
- 3378US2024050437A1Heterocyclic compounds and uses thereofINFINITY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3477US2024391884A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2024·Application pending·0 cites
- 3568US2018072801A1Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2017·Application pending·0 cites
- 3666US9657095B2Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2015·Granted May 23, 2017·0 cites·22 claims
- 3762US8986685B2Compositions and methods for increasing bone mineralizationUCB PHARMA SA·Filed 2012·Granted Mar 24, 2015·0 cites·11 claims
- 3861US2011206677A1Antibodies specific for sclerostin and methods for increasing bone mineralizationUCB MFG INC·Filed 2011·Application pending·0 cites
- 3960US2011195453A1Antibodies Specific for Sclerostin and Methods for Increasing Bone MineralizationUCB MFG INC·Filed 2010·Application pending·0 cites
- 4060US2023079631A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2022·Application pending·0 cites
- 4159US2011206678A1Antibodies Specific for Sclerostin and Methods for Increasing Bone MineralizationUCB MFG INC·Filed 2011·Application pending·0 cites
- 4258US2010015665A1Antibodies and diagnosticsUCB PHARMA SA·Filed 2007·Application pending·0 cites
- 4355US2013267689A1Antibodies and diagnosticsUCB PHARMA SA·Filed 2013·Application pending·0 cites
- 4453US2004009535A1Compositions and methods for increasing bone mineralizationCELLTECH R & D INC·Filed 2003·Application pending·0 cites
- 4553US2021395241A1Nlrp modulatorsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4651USRE46943ERadioprotector compounds and methodsPETER MACCALLUM CANCER INST·Filed 2011·Granted Jul 10, 2018·0 cites·20 claims
- 4749US2022339169A1Methods of treating or selecting a treatment for a subject resistant to tnf inhibitor using a nlrp3 antagonistNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4848US2023059136A1The compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
- 4948US2023051589A1Compounds and compositions for treating conditions associated with nlrp activityNOVARTIS AG·Filed 2019·Application pending·0 cites
- 5046US2022267276A1Nlrp modulatorsNOVARTIS AG·Filed 2019·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →